The innovative drug sector on the Hong Kong stock market rose in late trading, with CanSino Biologics (09926.HK) and Sino Biopharmaceutical (01530.HK) up more than 6%, WuXi Biologics (02269.HK), Hutchison China MediTech (00013.HK), and Innovent Biologics (01801.HK) rose more than 5%, while WuXi AppTec (02359.HK) gained more than 4%.
Source:富途快讯 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Hong Kong 'Lonely Heart' Scammed for $3.3M in Crypto Romance Investment Fraud; Malaysian Authorities Express Displeasure Over Blockchain Week After-Party's OnlyFans Scandal
-
2
Microsoft's stock is on a run not seen in 26 years, erasing its year-to-date losses
-
3
FBI Agent Accused of Stealing $1 Million in Crypto, Allegedly Used ChatGPT for Vacation Plans
-
4
DIA Coin: A Deep Dive into the Web3 Decentralized Data Oracle Platform and its Future Outlook
-
5
TRX Latest Price $0.33: Will TRON Coin Still Be Worth Holding in H2 2026?
-
6
Bitcoin Future Purchase Difficulty Analysis: Scarcity, Regulation, and Market Trends
-
7
FIDA Token Value Potential Analysis: Its Role and Future Prospects in the Solana Name Service Ecosystem
-
8
SpaceX is tightening its supply chain to reduce Chinese influence, aiming to keep Chinese nationals and parts out.
-
9
JFI Coin: JackPool.finance Project Analysis and Market Performance Overview
-
10
DOS Network (DOS) Project Analysis: Current Status and Future Outlook of Decentralized Oracles
Markets Today
Recommended Reading








